Teva Pharmaceuticals USA, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 969
Rang # Quantité totale PI 1 365
Note d'activité PI 3,3/5.0    349
Rang # Activité PI 2 054
Parent Teva Pharmaceutical Industries Ltd.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

22 202
0 39
658 2
46
 
Dernier brevet 2024 - Pre-filled syringe
Premier brevet 1997 - Process for the preparation of t...
Dernière marque 2025 - ONHIRA
Première marque 1998 - GALZIN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nerv...
P/S Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacem...
2024 P/S Pharmaceutical preparations for the treatment of autoimmune diseases Injectors for medical purpos...
P/S Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders...
P/S Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases
P/S Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, can...
P/S Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune disea...
P/S Pharmaceutical preparations, namely, oral contraceptives.
2023 Invention Pre-filled syringe. An auto-injector device includes a pre-filled syringe including a container ...
P/S Medical services, namely, providing information relating to tardive dyskinesia to medical and hea...
P/S Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutic...
P/S Contraceptive preparations; pharmaceutical preparations for use in the treatment of fertility dis...
Invention Processes for the preparation of finerenone. The present disclosure encompasses processes for the...
P/S Pharmaceutical products for treatment of neurological diseases Pharmaceutical research services, ...
Invention Solid state forms of lx9211 and salts thereof. The present disclosure encompasses solid state for...
Invention Solid state forms of tolebrutinib and of tolebrutinib salts. The present disclosure encompasses s...
Invention Crystalline forms of trilaciclib and trilaciclib salts. The present disclosure encompasses solid ...
Invention Solid state forms of gusacitinib. The present disclosure encompasses solid state forms of Gusacit...
Invention Solid state forms of seltorexant. Solid state forms of Seltorexant HCl and processes for preparat...
Invention Solid state forms of danicopan and process thereof. The present disclosure relates to Danicopan s...
Invention Processes for preparation of avacopan and intermediates thereof. The present disclosure encompass...
P/S Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents f...
Invention Solid state forms of tipifarnib and process for preparation thereof. The present disclosure encom...
Invention Solid state forms of rucaparib tosylate. The present disclosure encompasses solid state forms of ...
2022 Invention Improved processes for the preparation of ripretinib. The present invention relates to safe and i...
Invention Solid state forms of lotilaner and process for preparation thereof. The present disclosure encomp...
Invention Solid state forms of deucravacitinib, deucravacitinib hcl and process for preparation of deucrava...
Invention Solid state forms of tavapadon and processes for preparation thereof. The present disclosure enco...
Invention Solid state forms of nirogacestat salts. The present disclosure encompasses solid state forms of ...
Invention Solid state form of tafamidis. The present disclosure relates to a solid state form of Tafamidis,...
Invention Solid state forms of ensifentrine and process for preparation thereof. The present disclosure enc...
Invention Solid state forms of elacestrant and processes for preparation thereof. The present invention con...
Invention Solid state forms of ipatasertib citrate. The present invention encompasses salts and solid state...
Invention Solid state forms of vericiguat and process for preparation thereof. The present disclosure encom...
Invention Polymorphs of ponesimod. The present disclosure encompasses Ponesimod crystalline forms, processe...
Invention Solid state forms of amcenestrant. The present disclosure encompasses solid state forms of Amcene...
Invention Solid state forms of 4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7- yl]oxymethyl]-n-methylpyridin...
Invention Solid state forms of abexinostat and process for preparation thereof. Solid state forms of Abexin...
Invention Solid state forms of lanifibranor and process for preparation thereof. The present disclosure enc...
Invention Solid state form of centanafadine hcl and process for preparation thereof. The present disclosure...
Invention Process for preparation of sotorasib and solid state form thereof. The present disclosure relates...
Invention Solid state forms of sitravatinib salts and processes for preparation thereof. The present disclo...
Invention Solid state forms of zavegepant and process for preparation thereof. The present disclosure encom...
Invention Solid state forms of firibastat and processes for preparation thereof. The present disclosure enc...
Invention Solid state forms of zandelisib and salts thereof. The present disclosure encompasses solid state...
Invention Solid state forms of tideglusib and process for preparation thereof. The present disclosure encom...
Invention Unhydrous crystalline form of omecamtiv mecarbil dihydrobromide salt. The present disclosure rela...
Invention Solid state forms of capivasertib and process for preparation thereof. The present disclosure enc...
2021 Invention Processes for the preparation of zanubrutinib and intermediates thereof. The present disclosure p...
Invention Uv-leds photoreactor apparatus and associated methods. Aspects of the present disclosure relate t...
Invention Solid state forms of pralsetinib and process for preparation thereof. The present disclosure enco...
Invention Solid state forms of resmetirom. The present disclosure encompasses solid state forms of Resmetir...
Invention Solid state forms of lorecivivint. The present disclosure encompasses solid state forms of Loreci...
Invention Solid state forms of trilaciclib and of trilaciclib salts. The present disclosure encompasses sol...
Invention Solid state forms of gefapixant and process for preparation thereof. The present disclosure encom...
Invention Solid state forms of sep-363856 and process for preparation thereof. Solid state forms of SEP-363...
Invention Solid state forms of at-001 and process for preparation thereof. The present disclosure encompass...
Invention Solid state forms of erdafitinib salts and processes for preparation of erdafitinib. The present ...
Invention Solid state forms of fezolinetant and salts thereof. The present disclosure encompasses solid sta...
Invention Solid state forms of ensartinib and ensartinib salts. The present disclosure encompasses solid st...
Invention Solid state forms of belumosudil and belumosudil salts. The present disclosure encompasses solid ...
Invention Solid state forms of selpercatinib and process for preparation thereof. The present disclosure en...
Invention Solid state forms of rucaparib salts. The present disclosure encompasses solid state forms of Ruc...